To evaluate the association between the presence of demarcated opacities in primary canines and the occurrence of hypomineralized second primary molars (HSPM) in a group of Brazilian children. Dental records from 232 patients aged 5–10 years were evaluated by a single trained and calibrated examiner using the diagnostic criteria of the European Academy of Paediatric Dentistry (EAPD). The presence, severity, and clinical characteristics of enamel defects were recorded. Data were analyzed using descriptive statistics, Fisher's exact test, and binomial logistic regression to assess the association between primary canine involvement (exposure) and HSPM (outcome). The prevalence of HSPM was 20.7% (48/232 children) at the patient level and 15.8% (147/928 teeth) at the tooth level, with no significant differences according to sex or age. Among affected children, 68.8% presented mild lesions, whereas 31.2% had at least one severely affected molar. Demarcated opacities were the most common clinical presentation (76.9%). Logistic regression revealed that each additional affected primary canine was associated with a 6.12-fold increase in the odds of HSPM (OR = 6.12; 95%CI: 1.79–20.96; Nagelkerke R2 = 0.145). There was an association between demarcated opacities in primary canines and HSPM. Involvement of primary canines may serve as a clinical marker for the occurrence of HSPM, supporting the implementation of early screening and preventive strategies.
12 August 2026 in European Archives of Paediatric Dentistry
Purpose: To provide an updated review of the literature and systematically estimate the global prevalence of hypomineralised second primary molars (HSPM). Methods: A comprehensive literature search was conducted across PubMed, Web of Science, Scopus, Embase, SciELO and LILACS electronic databases following PRISMA guidelines. The grey literature search was conducted on Google Scholar. Observational studies reporting prevalence data of HSPM were included. Risk of bias was assessed using the Joanna Briggs Institute Checklist for Prevalence Studies. A random-effects meta-analysis was performed to estimate the pooled prevalence. Subgroup analyses were performed to explore potential sources of heterogeneity. Results: Sixty-one studies were included in the quantitative synthesis, comprising 52,874 participants and 127,841 primary molars. The pooled prevalence of HSPM was 10.7% (95% CI 8.0%–13.4%; I 2 = 98.6%) at the child-level and 5.2% (95% CI 2.9%–7.4%; I 2 = 99.0%) at the tooth-level. Subgroup analyses showed geographic origin as a significant source of variation ( p < 0.001), with the highest prevalence in Oceania (15.2%) and the lowest in Africa (3.0%). Conversely, diagnostic criteria ( p = 0.073), examination method ( p = 0.977), and sex distribution (13.1% in females vs. 12.0% in males) did not significantly influence the prevalence estimates. Conclusion: The estimated global pooled prevalence of HSPM was 10.7% at the child-level and 5.2% at the tooth-level, representing an increase compared with previous global estimates, with geographic region contributing to its wide variability.
28 March 2026 in Journal of Esthetic and Restorative Dentistry
Introdução: o carcinoma epidermoide de cabeça e pescoço (CECP) é um tipo de tumor maligno bastante comum no mundo, que possui taxas de sobrevida preocupantes. Portanto, estabelecer biomarcadores, como o SOX2, que está associado a proliferação de células tronco cancerígenas (CTCs), é importante para se detectar precocemente a doença, bem como determinar o prognóstico, auxiliando no tratamento. Objetivo: analisar a atuação do SOX2 como preditor prognóstico para o CECP. Metodologia: trata-se de uma revisão sistemática da literatura realizada nas bases de dados BVS, PUBMED, Web of Science e SCOPUS, a partir da estratégia “SOX2 AND (oral squamous cell carcinoma OR head and neck squamous cell carcinoma) AND (prognosis OR aggressiveness)”. A amostra final foi composta por 19 artigos. Resultados: os dados de sobrevida demonstraram divergência entre os trabalhos: 10 estudos concluíram que a maior expressão de SOX2 associa-se a bom prognóstico, enquanto 8 concluíram o oposto. 1 artigo não apontou relação entre esses fatores. Foram analisados dados sobre ocorrência de metástases, transição epitelial mesenquimal, proliferação e invasão tumoral, resultado a radioterapia, grau, diferenciação e tamanho do tumor, sendo os apontamentos divergentes entre estudos. Conclusão: os achados clínicos apontam relações existentes entre SOX2 e o CECP, todavia, não de forma conclusiva. Assim, a literatura não respalda o uso de SOX2 como preditor prognóstico, reforçando a necessidade de elucidar os mecanismos e vias moleculares através das quais SOX2 influencia a progressão do câncer.